Cascone T, Bonanno L, Guisier F, Insa A, et al. Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial. Nat Med 2025 May 31. doi: 10.1038/s41591-025-03746.
PMID: 40450142